A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients-Reference-Cited by-同舟云学术

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

Published:1996-01 Issue:1 Volume:20 Page:57-71
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Dieric Michel,Ravizza Ujigi,Realini Renzo,Martin Alain

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference24 articles.

1. The Evidence For 20 Mg a Day of Fluoxetine as The Optimal Dose in the Treatment of Depression;Altamura;Br. J. Psychiatry,1988

2. Fluoxetine: Relationships Among Dose, Response, Adverse Events, and Plasma Concentrations in the Treatment of Depression;Beasley;Psychopharmacol. Bull.,1990

3. A Randomised, Double-Blind Comparison of a Rapidly Escalating Dose of Venlafaxine and Imipramine in Inpatients with Major Depression and Melancholia (Abstract);Benkert;Neuropsychopharmacology,1994

4. Blockade By Newly-Developed Antidepressants Of Biogenic Amine Uptake Into Rat Brain Synaptosomes;Bolden-Watson;Life Sciences,1993

5. A Double-Blind Comparison of Venlafaxine and Fluoxetine in Patients Hospitalized for Major Depression and Melancholia;Clerc;Int. Clin. Psychopharmacol.,1994

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In perspective of specific symptoms of major depressive disorder: Functional connectivity analysis of electroencephalography and potential biomarkers of treatment response;Journal of Affective Disorders;2024-08

2. The role of serotonin in depression—A historical roundup and future directions;Journal of Neurochemistry;2024-03-13

3. Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine;Psychopharmacology;2022-08-10

4. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study;BMC Psychiatry;2021-05-19

5. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect;Journal of Affective Disorders;2021-02